58 related articles for article (PubMed ID: 38485838)
21. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
22. Potential Prognostic and Diagnostic Values of CDC6, CDC45, ORC6 and SNHG7 in Colorectal Cancer.
Hu Y; Wang L; Li Z; Wan Z; Shao M; Wu S; Wang G
Onco Targets Ther; 2019; 12():11609-11621. PubMed ID: 32021241
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the dimeric CMG/pre-initiation complex and its transition into DNA replication forks.
Liu L; Zhang Y; Zhang J; Wang JH; Cao Q; Li Z; Campbell JL; Dong MQ; Lou H
Cell Mol Life Sci; 2020 Aug; 77(15):3041-3058. PubMed ID: 31728581
[TBL] [Abstract][Full Text] [Related]
24. Protein phosphatase 2A controls ongoing DNA replication by binding to and regulating cell division cycle 45 (CDC45).
Perl AL; O'Connor CM; Fa P; Mayca Pozo F; Zhang J; Zhang Y; Narla G
J Biol Chem; 2019 Nov; 294(45):17043-17059. PubMed ID: 31562245
[TBL] [Abstract][Full Text] [Related]
25. KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis.
Yang S; Ren X; Liang Y; Yan Y; Zhou Y; Hu J; Wang Z; Song F; Wang F; Liao W; Liao W; Ding Y; Liang L
Oncogene; 2020 Jan; 39(2):249-261. PubMed ID: 31477839
[TBL] [Abstract][Full Text] [Related]
26. LncRNA FOXD2-AS1 Functions as a Competing Endogenous RNA to Regulate TERT Expression by Sponging miR-7-5p in Thyroid Cancer.
Liu X; Fu Q; Li S; Liang N; Li F; Li C; Sui C; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2019; 10():207. PubMed ID: 31024447
[TBL] [Abstract][Full Text] [Related]
27. Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report.
Huang J; Li Y; Lu Z; Che Y; Sun S; Mao S; Lei Y; Zang R; Li N; Zheng S; Liu C; Wang X; Sun N; He J
Cell Oncol (Dordr); 2019 Aug; 42(4):571-578. PubMed ID: 30887286
[TBL] [Abstract][Full Text] [Related]
28. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
Hu Q; Tai S; Wang J
Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052
[TBL] [Abstract][Full Text] [Related]
29. LncRNA FOXD2-AS1 accelerates the papillary thyroid cancer progression through regulating the miR-485-5p/KLK7 axis.
Zhang Y; Hu J; Zhou W; Gao H
J Cell Biochem; 2019 May; 120(5):7952-7961. PubMed ID: 30456805
[TBL] [Abstract][Full Text] [Related]
30. Cell adhesion is regulated by CDK1 during the cell cycle.
Jones MC; Askari JA; Humphries JD; Humphries MJ
J Cell Biol; 2018 Sep; 217(9):3203-3218. PubMed ID: 29930204
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer.
Xu TP; Wang WY; Ma P; Shuai Y; Zhao K; Wang YF; Li W; Xia R; Chen WM; Zhang EB; Shu YQ
Oncogene; 2018 Sep; 37(36):5020-5036. PubMed ID: 29789713
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA FOXD2-AS1 contributes to colorectal cancer proliferation through its interaction with microRNA-185-5p.
Zhu Y; Qiao L; Zhou Y; Ma N; Wang C; Zhou J
Cancer Sci; 2018 Jul; 109(7):2235-2242. PubMed ID: 29737580
[TBL] [Abstract][Full Text] [Related]
33. Low Expression of Long Noncoding RNA IRAIN Is Associated with Poor Prognosis in Non-M3 Acute Myeloid Leukemia Patients.
Pashaiefar H; Izadifard M; Yaghmaie M; Montazeri M; Gheisari E; Ahmadvand M; Momeny M; Ghaffari SH; Kasaeian A; Alimoghaddam K; Ghavamzadeh A
Genet Test Mol Biomarkers; 2018 May; 22(5):288-294. PubMed ID: 29634410
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA FOXD2-AS1 aggravates nasopharyngeal carcinoma carcinogenesis by modulating miR-363-5p/S100A1 pathway.
Chen G; Sun W; Hua X; Zeng W; Yang L
Gene; 2018 Mar; 645():76-84. PubMed ID: 29248577
[TBL] [Abstract][Full Text] [Related]
35. Microarray bioinformatics in cancer- a review.
Tao Z; Shi A; Li R; Wang Y; Wang X; Zhao J
J BUON; 2017; 22(4):838-843. PubMed ID: 29155508
[TBL] [Abstract][Full Text] [Related]
36. MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.
Shi Q; Zhou Z; Ye N; Chen Q; Zheng X; Fang M
Cancer Biomark; 2017 Dec; 20(4):539-546. PubMed ID: 28946554
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic work-up of acute myeloid leukemia.
Weinberg OK; Sohani AR; Bhargava P; Nardi V
Am J Hematol; 2017 Mar; 92(3):317-321. PubMed ID: 28066929
[TBL] [Abstract][Full Text] [Related]
38. Long Non-Coding RNAs: New Players in Hematopoiesis and Leukemia.
Morlando M; Ballarino M; Fatica A
Front Med (Lausanne); 2015; 2():23. PubMed ID: 25927065
[TBL] [Abstract][Full Text] [Related]
39. Targeting cell cycle regulators in hematologic malignancies.
Aleem E; Arceci RJ
Front Cell Dev Biol; 2015; 3():16. PubMed ID: 25914884
[TBL] [Abstract][Full Text] [Related]
40. The expression of CDK1 is associated with proliferation and can be a prognostic factor in epithelial ovarian cancer.
Xi Q; Huang M; Wang Y; Zhong J; Liu R; Xu G; Jiang L; Wang J; Fang Z; Yang S
Tumour Biol; 2015 Jul; 36(7):4939-48. PubMed ID: 25910705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
